CCND1 and colorectal cancer: Meta-analysis of 10 studies showed that high cyclin D1 expression was associated with poor DFS in colorectal cancer patients (HR: 0.60, 95% CI: 0.44–0.82, P = 0.001, and I2 = 23.7%, P = 0.225 for heterogeneity) (Figure 3).